Literature DB >> 9184680

Cancer incidence and mortality: the priority of screening frequency and population coverage.

G A Colditz1, D C Hoaglin, C S Berkey.   

Abstract

In addition to the usual measures of screening-test performance, it is important to consider testing frequency when evaluating a screening program. Data on which to base recommendations for the timing of screening tests are urgently needed. For example, in the cases of cervical and colon cancer, when the target is a precursor lesion, research indicates that less frequent screening may be appropriate. This finding may not apply, however, to screening for breast cancer by mammography, which requires currently recommended intervals for the early detection of malignancies. Resources now allocated to breast cancer might more effectively be applied to the construction of tests that would permit longer intervals between screenings. To achieve the National Cancer Institute's goal of reducing cancer mortality in the United States by the year 2000, it will be important to review the balance between population coverage and individual screening for each cancer and to emphasize prevention strategies that maximize population coverage while minimizing expenditures.

Entities:  

Keywords:  Americas; Cancer; Causes Of Death; Demographic Factors; Developed Countries; Diseases; Examinations And Diagnoses; Mortality; Neoplasms; North America; Northern America; Organization And Administration; Policy; Population; Population Dynamics; Program Effectiveness; Program Evaluation; Programs; Research Methodology; Screening; Social Policy; United States

Mesh:

Year:  1997        PMID: 9184680      PMCID: PMC2751047          DOI: 10.1111/1468-0009.00050

Source DB:  PubMed          Journal:  Milbank Q        ISSN: 0887-378X            Impact factor:   4.911


  8 in total

1.  Why reduce health inequalities?

Authors:  A Woodward; I Kawachi
Journal:  J Epidemiol Community Health       Date:  2000-12       Impact factor: 3.710

2.  Delivering equitable care: comparing preventive services in Manitoba.

Authors:  Sumit Gupta; Leslie L Roos; Randy Walld; Dawn Traverse; Matthew Dahl
Journal:  Am J Public Health       Date:  2003-12       Impact factor: 9.308

3.  Transdisciplinary training in cancer prevention: reflections on two decades of training.

Authors:  Graham A Colditz; Kathleen Y Wolin
Journal:  J Cancer Educ       Date:  2011-09       Impact factor: 2.037

4.  The frequency of Pap smear screening in the United States.

Authors:  Brenda E Sirovich; H Gilbert Welch
Journal:  J Gen Intern Med       Date:  2004-03       Impact factor: 5.128

5.  Screening practice and misplaced priorities.

Authors:  Davide Mauri; Antonis Valachis; Nikolaos P Polyzos; Ivan Cortinovis; Vassiliki Karampoiki; Evridiki Loukidou; Paraskevi Alevizaki; Konstantinos Kamposioras; Georgios Kouris; Parthenopi Alexandropoulou; Lamprini Tsali; Charalampos Panou; Athanasios Stamatelopoulos; Velisarios Lakiotis; Anastasia Spiliopoulou; Aikaterini Terzoudi; Aliki Ioakimidou; Ioanna Karathanasi; Magdalini Bristianou; Giovanni Casazza; Nicholas Pavlidis
Journal:  Clin Transl Oncol       Date:  2009-04       Impact factor: 3.405

6.  Physical activity as a determinant of fecal bile acid levels.

Authors:  Betsy C Wertheim; María Elena Martínez; Erin L Ashbeck; Denise J Roe; Elizabeth T Jacobs; David S Alberts; Patricia A Thompson
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-04-21       Impact factor: 4.254

7.  The Prevention Index: using technology to improve quality assessment.

Authors:  Thomas M Vogt; Mikel Aickin; Faruque Ahmed; Mark Schmidt
Journal:  Health Serv Res       Date:  2004-06       Impact factor: 3.402

Review 8.  Prevention trials: their place in how we understand the value of prevention strategies.

Authors:  Graham A Colditz; Philip R Taylor
Journal:  Annu Rev Public Health       Date:  2010       Impact factor: 21.981

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.